Intraputaminal AAV9 co-delivery of AADC and GDNF in severe AADC deficiency: first-in-human pediatric dose-escalation study.
First-in-human findings support a dual-gene "enzyme restoration plus circuit support" paradigm and provide a strong translational rationale for further clinical development of this next-generation gene therapy for severe AADC deficiency.